ZHEJIANG JINGXIN PHARMACEUTICAL
Up to now, the company has a registered capital of 725 million yuan, total assets of 5.3 billion yuan and net assets of 3.6 billion yuan. The company has more than 2,900 employees, including more than 230 masters.The company has two headquarters in Xinchang and Hangzhou. It has six production sites including the plant in Xinchang for finished medicines, the two API plants in Shangyu and Shangrao, the TCM production site in Bayannaoer, Inner Mongolia, and the medical equipment production base of ... Shenzhen and Shenyang. Aside from that, the company also owns a breeding base in Yunnan. In Shanghai, the company has established its own research institute i n the Zhangjiang Hi-Tech Park. Joint ventures and collaberated labs have also been founded over the years in the U.S.A., the U.K., Denmark, Isereal, Korea as well as other countries.
ZHEJIANG JINGXIN PHARMACEUTICAL
Social Links:
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
1990-01-01
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Analytics Content Delivery Network SSL By Default Mobile Non Scaleable Content HSTS Google Universal Analytics
Similar Organizations
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma is pharmaceutical company.
Oncogenpharma
Oncogenpharma is a healthcare pharmaceutical-based medical products manufacturing agency.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Sinphar Pharmaceutical
Sinphar Pharmaceutical is a pharmaceutical group that focuses on R&D, production and marketing.
Southern Pharma
Southern Pharma is a cGMP pharmaceutical company integrating R&D, production, and sales.
SRK Life Sciences
SRK Life Sciences is pharmaceutical company delivering wide range of products and services.
Sunshine Guojian Pharmaceutical Shanghai
Sunshine Guojian Pharmaceutical Shanghai is a biopharmaceutical company that provides antibody drugs.
Zhitong Biopharmaceutical
Zhitong Biopharmaceutical is a pharmaceutical enterprise integrating biochemical research, production, and sales.
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-09 | Shaxi Pharmaceutical | Shaxi Pharmaceutical acquired by Zhejiang Jingxin Pharmaceutical | 205 M CNY |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-05-15 | Ai Ma Biology | Zhejiang Jingxin Pharmaceutical investment in Angel Round - Ai Ma Biology | N/A |
| 2021-11-09 | Huqing Yutang | Zhejiang Jingxin Pharmaceutical investment in Corporate Round - Huqing Yutang | 210 M CNY |
More informations about "Zhejiang Jingxin Pharmaceutical"
่ตฐ่ฟไบฌๆฐ-ไบฌๆฐ่ฏไธ
Founded in 1990, Zhejiang Jingxin Pharmaceutical Co., Ltd. is a listed pharmaceutical company integrating R&D, production and sales. Adhering to the business guideline of โstrengthening โฆSee details»
Zhejiang Jingxin Pharmaceutical - Crunchbase
Zhejiang Jingxin Pharmaceutical is a listed pharmaceutical company integrating R&D, production and sales. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... 670 Number of Organizations โข $98.1B โฆSee details»
Zhejiang Jingxin Pharmaceutical Co., Ltd. | LinkedIn
Zhejiang Jingxin Pharmaceutical Co., Ltd. | 1,008 followers on LinkedIn. Practicability, Innovation, Inclusiveness, Win-Win. | Up to now, the company has a registered capital of 725 million yuan ...See details»
Zhejiang Jingxin Pharmaceutical Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Zhejiang Jingxin Pharmaceutical Co., Ltd. of Shaoxing, Zhejiang. Get the latest business insights from โฆSee details»
Zhejiang Jingxin Pharmaceutical Company - PitchBook
Nov 7, 2016 Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections โฆSee details»
Zhejiang Jingxin Pharmaceutical Co Ltd: Overview - GlobalData
Zhejiang Jingxin Pharmaceutical Co Ltd (Jingxin Pharma) is a manufacturer of Chinese medicine. The company offers products such as finished dosage forms, Chinese herbal drugs and APIs. โฆSee details»
Zhejiang Jingxin Pharmaceutical Co.,Ltd. (China) - EMIS
Nov 10, 2024 Financial values in the chart are available after Zhejiang Jingxin Pharmaceutical Co.,Ltd. report is purchased. Looking for more than just a company report? EMIS company โฆSee details»
Company Zhejiang Jingxin Pharmaceutical Co., Ltd.
Sep 15, 2004 Company Zhejiang Jingxin Pharmaceutical Co., Ltd. Equities 002020 CNE000001K73 Pharmaceuticals End-of-day quote Shenzhen S.E. Other stock markets. 2024 โฆSee details»
Zhejiang Jingxin Pharmaceutical - Funding, Financials, Valuation ...
Jul 15, 2004 Zhejiang Jingxin Pharmaceutical is a listed pharmaceutical company integrating R&D, production and sales.See details»
Zhejiang Jingxin Pharmaceutical Company Profile - Craft
Zhejiang Jingxin Pharmaceutical is a company that manufactures and markets medical, pharmaceutical. and healthcare products. It offers capsules, tablets, pharmaceutical products, โฆSee details»
Zhejiang Jingxin Pharmaceutical - Investments, Portfolio
Zhejiang Jingxin Pharmaceutical has made 2 investments. Their most recent investment was on May 15, 2023, when Ai Ma Biology raised Zhejiang Jingxin Pharmaceutical has acquired Shaxi โฆSee details»
Zhejiang Jingxin Pharmaceutical Co., Ltd. ESG Risk Rating
Oct 14, 2024 Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms โฆSee details»
Mapi Pharma Ltd. Announces Closing of $10 Million Investment by ...
Nov 5, 2018 About Jingxin Pharmaceutical Co., Ltd. Zhejiang Jingxin Pharmaceutical Company Ltd. is a public Chinese company (SHE:002020) focused on developing novelty and generic โฆSee details»
Dimdazenil Capsules Approved for Marketing by China NMPA
Recently, the Category 1 innovative drug Dimdazenil Capsules of Zhejiang Jingxin Pharmaceutical Co., Ltd. was approved for marketing by China NMPA. This drug is indicated โฆSee details»
Shaoxing enterprise's innovation dream in capsules
Feb 27, 2024 Zhejiang Jingxin Pharmaceutical Co, headquartered in Shaoxing, is racing to mass-produce a revolutionary type of miniature pills at the commencement of the Chinese โฆSee details»
Jingxin in-licensing epilepsy drug from Bio-Pharm Solutions
Aug 31, 2021 Zhejiang Jingxin Pharmaceutical Co. Ltd. has in-licensed JBPOS-0101, a class I new drug for epilepsy, from Bio-Pharm Solutions Co. Ltd. for mainland China, Hong Kong, and โฆSee details»
Zhejiang Jingxin Pharmaceutical Co., Ltd - Google
Get the latest Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) real-time quote, historical performance, charts, and other financial information to help you make more informed trading โฆSee details»
JX2105 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 JX2105, Initially developed by Zhejiang Jingxin Pharmaceutical Co., Ltd., Now, its global highest R&D status is Phase 1, Therapeutic Areas: Nervous System Diseases ...See details»
Zhejiang Jingxin Pharmaceutical Co., Ltd. - MarketScreener.com
1 day ago Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 21-08-26: CI Zhejiang Jingxin Pharmaceutical Co., Ltd. announced that โฆSee details»